The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,151.00
Bid: 1,150.50
Ask: 1,151.50
Change: 16.50 (1.45%)
Spread: 1.00 (0.087%)
Open: 1,136.50
High: 1,151.50
Low: 1,132.50
Prev. Close: 1,134.50
BRBY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on the Impact of COVID-19

19 Mar 2020 07:00

RNS Number : 7156G
Burberry Group PLC
19 March 2020
 

19 March 2020

 

Burberry Group plc

Update on the impact of COVID-19

 

"Since our February update, the material negative effect of COVID-19 on luxury demand has intensified and is now impacting the industry in all regions. Our primary concern is the global health emergency and we continue to take every precaution to help prevent the spread of the virus and ensure the safety and wellbeing of our employees, partners and customers. We are implementing mitigating actions to contain our costs and protect our financial position, underpinned by our strong balance sheet. We remain confident in our strategy and the strength of our brand and I am exceptionally proud of our teams' resilience and commitment." Marco Gobbetti, Chief Executive Officer

 

Given the ongoing escalation of the COVID-19 pandemic, we wanted to update the market on the impact on our business as we approach the end of FY 2020 (28 March 2020).

Since 24 January 2020, trading has deteriorated significantly with comparable retail store sales tracking between -40% and -50% over the last six weeks.

As we set out in our announcement on 7 February 2020, our sales losses in February were predominantly in our Asian markets. While trading in Mainland China has started to improve with the reopening of most of our stores, sales in EMEIA and the Americas have fallen materially in recent weeks. More than 60% of our stores in EMEIA and around 85% of our stores in the Americas are currently closed with those still open operating with reduced hours and with very weak footfall. In total, around 40% of our directly operated stores globally are closed with additional closures expected over the coming days.

Following the significant escalation of governmental trading, travel and social restrictions in recent days and the inevitable impact this will have on demand, we are expecting our comparable retail store sales in the final weeks of the year to be within the range of -70% to -80%. As a result, we now expect Q4 2020 comparable retail store sales to be around -30%.

We are implementing mitigating actions to contain costs and protect our financial position, including renegotiating rents, restricting travel and reducing discretionary spending. Our primary concern is the global health emergency and we are taking appropriate measures to help prevent the spread of the virus and ensure the safety and wellbeing of our employees, partners and customers, while following government guidelines in all our markets. These include implementing home working for the majority of our office-based teams and reducing work patterns and introducing specific shift rotations for teams whose roles cannot be performed remotely as well as putting in place strict protocols for hygiene and social distancing. 

We remain confident in the strength of our brand and our strategy. Until 24 January 2020, the consumer response to the new product was very positive and as such, we are protecting key growth initiatives in preparation for a recovery in luxury demand.

We have significant financial headroom including liquidity of £0.9bn from £0.6bn cash balances (before lease obligations) and a £0.3bn Revolving Credit Facility. In terms of leverage, at September 2019, we had £0.4bn of net debt including lease liabilities and we are operating with a net debt including lease liabilities to EBITDA ratio within our targeted range of 0.5x to 1.0x.

This announcement anticipates and replaces our planned extraordinary trading update in April. Our next scheduled announcement is our Preliminary Results in May 2020.

 

Enquiries

Investors and analysts

020 3367 4458

Annabel Gleeson VP, Investor Relations

Annabel.Gleeson@burberry.com

Media  

020 3367 3764

Andrew Roberts VP, Corporate Relations

Andrew.Roberts@burberry.com

 

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from any expected future results in forward-looking statements. Burberry Group plc undertakes no obligation to update these forward-looking statements and will not publicly release any revisions it may make to these forward-looking statements that may result from events or circumstances arising after the date of this document. Nothing in this announcement should be construed as a profit forecast. All persons, wherever located, should consult any additional disclosures that Burberry Group plc may make in any regulatory announcements or documents which it publishes. All persons, wherever located, should take note of these disclosures. This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

Notes to editors

Burberry is a global luxury brand with a distinctly British attitude.

Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. Its ADR symbol is OTC:BURBY.

BURBERRY, the Equestrian Knight Device, the Burberry Check and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCJPMBTMTJBTPM
Date   Source Headline
12th Apr 202410:12 amRNSDirectorate Change
2nd Apr 20243:17 pmRNSTotal Voting Rights
1st Mar 20241:00 pmRNSBlock listing Interim Review
1st Mar 202411:03 amRNSTotal Voting Rights
1st Feb 20244:33 pmRNSDirector/PDMR Shareholding
1st Feb 202412:16 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSTrading Update
11th Jan 20241:26 pmRNS2023 Annual General Meeting Voting Outcome Update
3rd Jan 20243:08 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:42 amRNSTotal Voting Rights
14th Dec 20233:37 pmRNSDirector/PDMR Shareholding
7th Dec 20234:19 pmRNSDirector/PDMR Shareholding
1st Dec 202311:57 amRNSTotal Voting Rights
17th Nov 20235:19 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSBurberry Group plc Interim Results
1st Nov 20231:51 pmRNSTotal Voting Rights
31st Oct 20235:26 pmRNSTransaction in Own Shares
30th Oct 20235:30 pmRNSTransaction in Own Shares
27th Oct 20235:28 pmRNSTransaction in Own Shares
26th Oct 20235:31 pmRNSTransaction in Own Shares
25th Oct 20235:27 pmRNSTransaction in Own Shares
24th Oct 20235:43 pmRNSTransaction in Own Shares
23rd Oct 20235:56 pmRNSTransaction in Own Shares
20th Oct 20235:30 pmRNSTransaction in Own Shares
19th Oct 20235:33 pmRNSTransaction in Own Shares
18th Oct 20235:53 pmRNSTransaction in Own Shares
17th Oct 20235:47 pmRNSTransaction in Own Shares
16th Oct 20235:45 pmRNSTransaction in Own Shares
13th Oct 20235:38 pmRNSTransaction in Own Shares
12th Oct 20235:39 pmRNSTransaction in Own Shares
11th Oct 20235:46 pmRNSTransaction in Own Shares
10th Oct 20235:30 pmRNSTransaction in Own Shares
9th Oct 20235:41 pmRNSTransaction in Own Shares
6th Oct 20235:19 pmRNSTransaction in Own Shares
5th Oct 20235:43 pmRNSTransaction in Own Shares
4th Oct 20235:53 pmRNSTransaction in Own Shares
3rd Oct 20235:23 pmRNSTransaction in Own Shares
2nd Oct 20235:37 pmRNSTransaction in Own Shares
2nd Oct 202311:28 amRNSTotal Voting Rights
28th Sep 20235:26 pmRNSTransaction in Own Shares
27th Sep 20235:15 pmRNSTransaction in Own Shares
26th Sep 20235:31 pmRNSTransaction in Own Shares
25th Sep 20235:37 pmRNSTransaction in Own Shares
22nd Sep 20239:23 amRNSDirector Declaration
15th Sep 20235:48 pmRNSTransaction in Own Shares
14th Sep 20235:47 pmRNSTransaction in Own Shares
13th Sep 20235:52 pmRNSTransaction in Own Shares
12th Sep 20235:46 pmRNSTransaction in Own Shares
11th Sep 20235:40 pmRNSTransaction in Own Shares
8th Sep 20235:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.